Ergéa UK, a vendor-neutral provider of Managed Equipment Services (MES), has published a comprehensive white paper exploring how modern MES solutions can help expand patient access to radiotherapy across the UK.
Titled “Radiotherapy MES: A Planned Long-Term Solution to the UK Radiotherapy Crisis,” the paper outlines how a radiotherapy MES provides a structured, funded, and strategic approach to addressing the NHS’s most urgent challenges in delivering equitable radiotherapy services.
As highlighted in the recent Darzi report, rising cancer incidence, missed treatment targets, aging infrastructure, and limited funding have created serious inequities in access to care. The Government’s recent £70 million investment in linear accelerators (LINACs) is a welcome step, yet it remains insufficient to tackle the deeper, systemic challenges that persist. Amidst ongoing crises and push for systemic change, the NHS faces mounting pressure to find sustainable solutions.
To ensure long-term success, the NHS must transition from short-term, reactive funding strategies to planned, proactive investment in technology and infrastructure. A modern MES can support this transformation by ensuring consistent access to advanced equipment, improving patient outcomes, and enhancing operational efficiency through long-term partnership models.
John Muolo, Executive Vice-President and Director of Strategic Relationships at Ergéa UK said: “We hope this white paper offers valuable insights into the potential of modern MES partnerships and provides guidance on factors to consider when selecting an MES supplier, always with the patient in mind.”
Download the full white paper here: https://bit.ly/RadiotherapyMES
